Many men who have received supplemental testosterone are seeking drug injury lawyers to represent them in court after the therapy resulted in serious side effects. In recent years, hormone replacement therapy has become immensely popular, but safety research into the treatment hasn’t caught up. Doctors caution against altering hormone levels because it can be highly unpredictable, but these concerns have been waved aside by marketers and pharmaceutical companies looking to make a handsome profit. With so many older men looking to capture lost youth, and younger men mistakenly believing the therapy can enhance their sexual performance, emotional claims have eclipsed the hard science. This has led to the development of dangerous medical conditions.
Why is supplemental testosterone being targeted by drug injury lawyers?
Only about 5 percent of men suffer from hypogonadism, which is a result of a low level of testosterone. For these men, the therapy can have significant benefits. However, pharmaceutical companies have managed to sway doctors and patients into believing that even men without hypogonadism can benefit from the treatment. There is little evidence to suggest this is true, and now that research is demonstrating serious side effects, these pharmaceutical companies may be responsible for false advertising and reckless behavior.
The problem with Low-T therapy is that it can worsen cardiovascular health, causing severe cardiac events in men who take hormone supplements for extended periods of time. A 2013 study published in The Journal of the American Medical Association followed nearly 9,000 men with low hormone levels and who had recently received a coronary angiography, a procedure that measures heart health. Among these 9,000 men were about 1,200 who were receiving hormone replacement. After a few years, the researchers followed up with the men and determined that, even after controlling for all other factors, hormone replacement therapy accounted for a six percent increase in risk of deadly heart conditions. Among these conditions were heart attack, congestive heart failure, and stroke. The study concluded that its findings were troubling enough to call for skepticism into the treatment’s benefits.
This was not the first study to reveal a danger with the treatment. In 2010, a study published in The New England Journal of Medicine examined more than 200 men, separated into a control group and a group that received hormone replacement. Though the study was fairly small, the researchers had to abort it because too many men who were receiving hormone supplements were developing serious heart problems. Unsurprisingly, the study also warned doctors to examine their patients carefully for cardiovascular risks before administering the treatment.
What is the status of lawsuits filed by supplemental testosterone victims and drug injury lawyers?
More than 200 cases have already been organized into multi-district litigation and are being sent to higher courts for examination. Several defendants have already been named, including Pfizer, Auxilium Pharmaceuticals, AbbVie and Pharmacia & Upjohn. The influx of litigation suggests that there will eventually be thousands of claims filed against the defendants as it is still early in the process.